The invention is directed to inhibitors of cystathionine beta synthase which, among other biochemical effects, allow reduction of the neurotoxic overproduction of endogenous hydrogen sulphide. These compounds and pharmaceutical compositions containing them are useful for the prevention and treatment of cognitive disorders such as cognitive disorders in Down syndrome. The invention also relates to methods for preventing or treating cognitive disorders including cognitive disorders in Down Syndrome.
本发明涉及胱
硫醚β合酶
抑制剂,除其他生化作用外,还允许减少内源性
硫化氢的神经毒性过度产生。这些化合物以及含有它们的药物组合物对于预防治疗认知障碍,如下氏综合症中的认知障碍等是有用的。本发明还涉及用于预防或治疗认知障碍的方法,包括下氏综合症中的认知障碍。